Table 3.

The prognostic value of plasma exosome-derived BTG-1 levels in NSCLC patients

Variable	NSCLC patients (n = 262)
AUROC (3-year DFS)	0.94(0.91-0.98)
Cutoff value (95%CI)	226.25
Sensitivity, %	91.0(81.5-96.6)
Specificity, %	82.3(72.1-90.0)
Positive predictive value, %	81.3(70.7-89.4)
Negative predictive value, %	91.5(82.5-96.8)
Positive likelihood ratio	5.14(3.2-8.3)
Negative likelihood ratio	0.11(0.05-0.2)
AUROC (3-year OS)	0.94(0.90-0.98)
Cutoff value (95%CI)	252.33
Sensitivity, %	81.7(69.6-90.5)
Specificity, %	93.0(85.4-97.4)
Positive predictive value, %	89.1(77.8-95.9)
Negative predictive value, %	87.9(79.4-93.8)
Positive likelihood ratio	11.71(5.4-25.6)
Negative likelihood ratio	0.20(0.1-0.3)